Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for ICU sedation
CTR20234238Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remimazolam, sponsored by Hengrui Therapeutics. Started Dec 2023; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on CTR20234238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234238.